Pulmonary Vein Isolation Outcomes With Fish Oils

NCT00841451 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2016-03-23

No results posted yet for this study

Summary

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

Conditions

Interventions

DRUG

Lovaza (Fish Oils)

Double blinded placebo controlled

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY
  • St. Luke's-Roosevelt Hospital Center

    lead OTHER

Principal Investigators

  • Suneet Mittal, MD · St. Luke's-Roosevelt Hospital Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00841451 on ClinicalTrials.gov